Mcl-1L Cytoplasmic Domain (human, recombinant)

Mcl-1L Cytoplasmic Domain (human, recombinant)

CAT N°: 33983
Price:

593.00 504.05

Myeloid cell leukemia-1 (Mcl-1) is a Bcl-2 family member protein that is involved in the regulation of apoptosis.{64165} Alternative splicing of MCL1 pre-mRNA produces three isoforms, anti-apoptotic Mcl-1 long (Mcl-1L) and pro-apoptotic Mcl-1 short and Mcl-1 extra short (Mcl-1S and Mcl-1ES, respectively). Mcl-1L is composed of a C-terminal helix that acts as a membrane anchor, four Bcl-2 homology (BH) domains, and a PEST domain. The BH1, BH2, and BH3 domains facilitate heterodimerization with pro-apoptotic proteins, including Bax and Bak, and homodimerization with Mcl-1S and Mcl-1ES.{64165,64166,64167} Mcl-1L is expressed during embryogenesis and hematopoiesis, as well as during nervous and immune system development, and localizes to the mitochondrial membrane.{55182,64168} It inhibits apoptosis by preventing Bax and Bak oligomerization, which form a pore on the outer mitochondrial membrane that allows release of cytochrome c into the cytoplasm.{64165} Knockdown of MCL1 sensitizes oral cancer cells to cisplatin and tumor levels of Mcl-1L are increased relative to adjacent normal tissues in patients with oral cancer.{64169} Overexpression of MCL1 is associated with poor prognosis in several cancers, including solid tumors and hematological malignancies.{64165} Cayman’s Mcl-1L Cytoplasmic Domain (human, recombinant) protein can be used for enzyme activity assays.

We also advise you